And in high quality studies, the pooled HR of UICC stage IV subgroup was 2.28(95%CI 1.60–3.25, I2 = 0%, fixed effect) (Fig 2B), indicating that high IL-8 expression was significantly correlated with poor prognosis for stage IV CRC patients. The gene discussed is CXCL8; the disease is colorectal carcinoma.